Original language | English |
---|---|
Pages (from-to) | 289-291 |
Number of pages | 3 |
Journal | Clinical Gastroenterology and Hepatology |
Volume | 12 |
Issue number | 2 |
DOIs | |
State | Published - Feb 2014 |
What is the value of a food and drug administration investigational new drug application for fecal microbiota transplantation to treat clostridium difficile infection?
Gail A. Hecht, Martin J. Blaser, Jeffrey Gordon, Lee M. Kaplan, Rob Knight, Loren Laine, Richard Peek, Mary Ellen Sanders, Balfour Sartor, Gary D. Wu, Vincent W. Yang
- Division of Laboratory and Genomic Medicine
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- Institute of Clinical and Translational Sciences (ICTS)
- Siteman Cancer Center
- Edison Family Center for Genome Sciences & Systems Biology
- DBBS - Molecular Cell Biology
- DBBS - Plant and Microbial Biosciences
- DBBS - Computational and Systems Biology
- DBBS - Molecular Microbiology and Microbial Pathogenesis
- Hope Center for Neurological Disorders
Research output: Contribution to journal › Editorial
18
Scopus
citations